These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 9346990

  • 1. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
    Seikaly MG, Brown R, Baum M.
    Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
    [Abstract] [Full Text] [Related]

  • 2. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G, Baroncelli GI, Bertelloni S, Perri G.
    J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
    [Abstract] [Full Text] [Related]

  • 3. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.
    Seikaly MG, Quigley R, Baum M.
    Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012
    [Abstract] [Full Text] [Related]

  • 4. X-linked hypophosphatemia: effects of treatment with recombinant human growth hormone.
    Reusz GS, Miltényi G, Stubnya G, Szabó A, Horváth C, Byrd DJ, Péter F, Tulassay T.
    Pediatr Nephrol; 1997 Oct; 11(5):573-7. PubMed ID: 9323282
    [Abstract] [Full Text] [Related]

  • 5. Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets.
    Haffner D, Nissel R, Wühl E, Mehls O.
    Pediatrics; 2004 Jun; 113(6):e593-6. PubMed ID: 15173542
    [Abstract] [Full Text] [Related]

  • 6. Recombinant growth hormone therapy for X-linked hypophosphatemia in children.
    Huiming Y, Chaomin W.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD004447. PubMed ID: 15674949
    [Abstract] [Full Text] [Related]

  • 7. Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone.
    Ertl DA, Le Lorier J, Gleiss A, Trabado S, Bensignor C, Audrain C, Zhukouskaya V, Coutant R, Berkenou J, Rothenbuhler A, Haeusler G, Linglart A.
    Orphanet J Rare Dis; 2022 Nov 12; 17(1):412. PubMed ID: 36371259
    [Abstract] [Full Text] [Related]

  • 8. Recombinant growth hormone therapy for X-linked hypophosphatemia in children.
    Smith S, Remmington T.
    Cochrane Database Syst Rev; 2021 Oct 07; 10(10):CD004447. PubMed ID: 34618915
    [Abstract] [Full Text] [Related]

  • 9. Effect of GH replacement therapy in two male siblings with combined X-linked hypophosphatemia and partial GH deficiency.
    Schütt SM, Schumacher M, Holterhus PM, Felgenhauer S, Hiort O.
    Eur J Endocrinol; 2003 Oct 07; 149(4):317-21. PubMed ID: 14514346
    [Abstract] [Full Text] [Related]

  • 10. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L, Clayton PE, Brain C, Pelekouda E, Addison GM, Price DA, Mughal MZ.
    Clin Endocrinol (Oxf); 1996 Jun 07; 44(6):687-96. PubMed ID: 8759181
    [Abstract] [Full Text] [Related]

  • 11. Changes in bone mineral density, growth velocity and renal function of prepubertal uremic children during growth hormone treatment.
    Lanes R, Gunczler P, Orta N, Bosquez M, Scovino R, Dominguez L, Esaa S, Weisinger JR.
    Horm Res; 1996 Jun 07; 46(6):263-8. PubMed ID: 8982736
    [Abstract] [Full Text] [Related]

  • 12.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Laurent MR, Harvengt P, Mortier GR, Böckenhauer D.
    ; 1993 Jun 07. PubMed ID: 22319799
    [Abstract] [Full Text] [Related]

  • 13. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L, Zou CC, Li Y, Wang CL, Jiang YJ, Dong GP, Fu JF, Wang XM.
    Zhonghua Er Ke Za Zhi; 2006 Sep 07; 44(9):657-61. PubMed ID: 17217656
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.
    Zhonghua Er Ke Za Zhi; 2009 Jan 07; 47(1):48-52. PubMed ID: 19573383
    [Abstract] [Full Text] [Related]

  • 15. A trial of growth hormone therapy in well-controlled hypophosphataemic rickets.
    Cameron FJ, Sochett EB, Daneman A, Kooh SW.
    Clin Endocrinol (Oxf); 1999 May 07; 50(5):577-82. PubMed ID: 10468922
    [Abstract] [Full Text] [Related]

  • 16. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ, Boniface AM, Schranck FW, Rupich RC, Whyte MP.
    J Bone Miner Res; 1992 Jun 07; 7(6):583-97. PubMed ID: 1414477
    [Abstract] [Full Text] [Related]

  • 17. Growth in X-linked hypophosphatemic rickets.
    Ariceta G, Langman CB.
    Eur J Pediatr; 2007 Apr 07; 166(4):303-9. PubMed ID: 17171343
    [Abstract] [Full Text] [Related]

  • 18. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR, Hamdy NA, Janssen YJ, Roelfsema F.
    J Clin Endocrinol Metab; 2001 Jul 07; 86(7):3079-85. PubMed ID: 11443170
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study.
    Mauras N, George D, Evans J, Milov D, Abrams S, Rini A, Welch S, Haymond MW.
    Metabolism; 2002 Jan 07; 51(1):127-35. PubMed ID: 11782884
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF, Miller BS, Dutailly P, Houchard A, Lawson E, Hale DE, Reiner B, Sperling MA, MS316 Study Group.
    Horm Res Paediatr; 2015 Jan 07; 83(4):268-79. PubMed ID: 25765099
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.